Acomplia - Pharmaceutical Products

Acomplia

ACOMPLIA® (rimonabant) approved in the European Union as an adjunct to diet and exercise for the treatment of obese patients (BMI ≥ 30 kg/m2), or overweight patients (BMI > 27 kg/m2) with associated risk factors such as type 2 diabetes or dyslipidemia.

	Price : €76.00

Acomplia - pharmaceutical products supplier is associated with Pfizer, GlaxoSmithKline, AstraZeneca and Sanofis Aventis specially in Europe. We offer pharmaceutical products for treatment cancer, arthritis, malaria, breathing problem, aging problems and other pharma drugs.